149 related articles for article (PubMed ID: 16797285)
1. Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation.
Franke GH; Trampenau C; Reimer J;
Transplant Proc; 2006 Jun; 38(5):1293-4. PubMed ID: 16797285
[TBL] [Abstract][Full Text] [Related]
2. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.
Margreiter R; Pohanka E; Sparacino V; Sperschneider H; Kunzendorf U; Huber W; Lameire N; Andreucci VE; Donati D; Heemann U;
Transpl Int; 2005 Jul; 18(7):816-23. PubMed ID: 15948861
[TBL] [Abstract][Full Text] [Related]
3. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
Prasad GV; Nash MM; Keough-Ryan T; Shapiro RJ
J Nephrol; 2010; 23(3):274-81. PubMed ID: 20383867
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
5. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.
Bäckman L; Aselius H; Lindberger K; Svensson L; Strömbom U; Olausson E; Hadimeri H; Deurell SI; Norrby J; Gäbel M; Ebermark A; Olausson M
Transplant Proc; 2006 Oct; 38(8):2654-6. PubMed ID: 17098029
[TBL] [Abstract][Full Text] [Related]
6. Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study.
Shihab FS; Waid TH; Conti DJ; Yang H; Holman MJ; Mulloy LC; Henning AK; Holman J; First MR;
Transplantation; 2008 May; 85(9):1261-9. PubMed ID: 18475181
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion.
Reimer J; Franke GH; Philipp T; Heemann U
Clin Transplant; 2002 Feb; 16(1):48-54. PubMed ID: 11982615
[TBL] [Abstract][Full Text] [Related]
8. Switching immunosuppression from cyclosporine to tacrolimus improves long-term kidney function: a 6-year study.
Hohage H; Welling U; Zeh M; Gerhardt U; Suwelack B
Transplant Proc; 2005 May; 37(4):1898-9. PubMed ID: 15919497
[TBL] [Abstract][Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile.
Woodside KJ; Nichols SD; Hunter GC; Gugliuzza KK; Daller JA
Transplant Proc; 2005 May; 37(4):1877-9. PubMed ID: 15919491
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life outcomes after kidney transplantation.
Fiebiger W; Mitterbauer C; Oberbauer R
Health Qual Life Outcomes; 2004 Jan; 2():2. PubMed ID: 14713316
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus and quality of life after kidney transplantation--a multicenter study.
Bohlke M; Rocha M; Gomes RH; Marini SS; Terhorst L; Barcellos FC; Hallal PC; Casarini D; Irigoyen MC
Clin Transplant; 2006; 20(4):504-8. PubMed ID: 16842529
[TBL] [Abstract][Full Text] [Related]
12. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
Marcard T; Ivens K; Grabensee B; Willers R; Helmchen U; Rump LC; Blume C
Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
[TBL] [Abstract][Full Text] [Related]
13. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
[TBL] [Abstract][Full Text] [Related]
14. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and tacrolimus: influence on cardiovascular risk factors.
Hohage H; Hillebrandt U; Welling U; Zeh M; Heck M; Gerhardt UW; Suwelack BM
Transplant Proc; 2005 Mar; 37(2):1036-8. PubMed ID: 15848615
[TBL] [Abstract][Full Text] [Related]
16. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
[TBL] [Abstract][Full Text] [Related]
17. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Gelens MA; Christiaans MH; v Hooff JP
Transplant Proc; 2005 May; 37(4):1900-1. PubMed ID: 15919498
[TBL] [Abstract][Full Text] [Related]
18. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
Gelens MA; Christiaans MH; van Hooff JP
Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
[TBL] [Abstract][Full Text] [Related]
20. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
Marcén R; Chahin J; Alarcón A; Bravo J
Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
